FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

7 letters match. Newest first.

  1. Extra Medication / www.extramedication.com

    FDA warned website Extra Medication for selling unapproved, misbranded ketamine drugs to U.S. consumers without prescriptions.

    High risk
  2. Skytron, LLC

    Skytron marketed four UV disinfection devices without FDA clearance or approval and kept unapproved medical claims after promising to remove them.

    High risk
  3. JJLBRO

    JJLBRO and Romvy E-Ticaret sold five male creams and sprays as unapproved new drugs on a website and Amazon.

    High risk
  4. TomboyX, PBC

    FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.

    Medium
  5. Matte Beauty

    FDA warned Matte Beauty that its chemical peel drugs are unapproved and sold with treatment claims.

    High risk
  6. Induction Therapies, LLC

    FDA warned Induction Therapies that its Collagen P.I.N. microneedling device is adulterated and misbranded because it lacks FDA marketing authorization.

    Medium
  7. Owlet Baby Care, Inc.

    FDA warns Owlet Baby Care that its Smart Sock baby monitors are adulterated devices sold without marketing approval.

    High risk